DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020" report to their offering.
Human Biobanking market is expected to reach US$37.1 billion 2020 primarily supported by application; Stem Cells, Blood and Blood Products, Research and Pharmaceuticals etc.
Among the Human Biobanking Application market, Advance Application is the fastest growing market with a CAGR of 9.65%. Organs and Research application in human banking together accounts approximately for 24% of the market share. Stem Cells, Blood and Blood Products, Research market with a positive growth rate during the period. Human Biobanking Industry is playing an increasing role in development of therapies and diagnosis of diseases with well-maintained researchers and institutions.
The report Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020 reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.
The report primarily focuses on:
- Emerging market trends
- Advancements in the technological space
- Market demand of the segments (by-region)
- Key growth areas and market size
- Key competitor's Edge
The analysis primarily deals with human biobanking applications market. Further, the subdivided categories include:
2.Blood1 & Blood Products
- c.Drug Discovery
1.Red Blood Cells, Plasma and Platelets
2.Tissue Sections, Liver, Eyes, Kidney, Brain, Heart and Other
3.DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.
4.Body Fluids (Synovial, Urine, Sputum, Buccal Scrapings and Sperm), Contract Services and Process Chemicals
More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 157 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Key Topics Covered:
B. Biobanking Benefits
C. Biospecimens (Collection, Processing, Storage, Retrieval And Disseminate)
D. Biobanking Principles
E. Path Breaking Technologies
F. Biobanking Performances
G. Biobank Applications
H. Biobank - Advanced Applications
I. Cancer Biobanking
J. Human Biobanking Applications - Geography Market Briefing
K. Human Biobanking Advanced Applications - Geography Market Briefing
Companies Mentioned - 35 of the 100+ Companies Featured
- Abbott Laboratories
- Acorda Therapeutics, Inc.
- Beckman Coulter, Inc.
- Biobank Ireland Trust
- Biokryo Gmbh
- Biolife Solutions, Inc.
- Biological Specimen Inventory System
- Biomatrica, Inc.
- Biorep Srl P.Iva
- Biostorage Technologies, Inc.
- Biostorage, Llc.
- Boehringer Ingelheim, Gmbh
- Cryo-Cell International, Inc.
- Cryo-Save, Ag
- Cryocord Sdn. Bhd.
- Cryolife, Inc.
- Cryologic Pty. Ltd.
- Cryomagnetics, Inc.
- Decode Genetics
- Dna Genotek, Inc.
- Labvantage Solutions, Inc.
- Labware, Inc.
- Lifegene Biobank
- Lifelines Cohort And Biobank (Lifelines)
- Lifeline® Cell Technology
- Lifenet Health
- Panasonic Biomedical Sales Europe B.V
- Promeddx, Llc
- Provia Laboratories, Llc
- Vital Therapies, Inc.
- Wheaton Science Products, Inc.
For more information visit http://www.researchandmarkets.com/research/dckdzs/human_biobanking